설명

Oncology is a branch of medicine that deals with the prevention, 진단, and treatment of cancer. Today, millions of people are living with cancer or have had cancer. Cancer is the second leading cause of death in the United States. The global oncology drugs market is set to grow by US$ 77.33 10억 동안 2021-2027, 연평균 성장률로 성장 (CAGR) ~의 7.4% 예측 기간 동안, 데이터 및 분석 회사 StrategyHelix에 따르면. Rising geriatric population, surge in prevalence of cancer, early screening of the cancer, and increase in R&D spending from pharmaceutical & biotechnology companies are expected to boost the market growth in the coming years.

이 보고서는 기간 동안 최신 시장 규모 데이터를 제공합니다. 2017-2020 그리고 예측 2027 covering key market aspects like sales value for oncology drugs. The global oncology drugs market is segmented on the basis of drug class, indication, 지역. By drug class, it is categorized into chemotherapy, hormone therapy, immunotherapy, and targeted therapy. The immunotherapy segment held the largest market share in 2020. By indication, the oncology drugs market is divided into breast cancer, colorectal cancer, lung cancer, multiple myeloma, non-hodgkin’s lymphoma, prostate cancer, 다른 사람. The lung cancer segment accounted for the largest market share in 2020. 지역에 따라, the oncology drugs market is divided into North America, 아시아 태평양, 유럽, 및 기타 국가 (열).

The report has profiled some of the key players of the market such as AbbVie Inc., Amgen Inc., Astellas Pharma Inc., AstraZeneca PLC, Bristol Myers Squibb (BMS), Eli Lilly and Company, 에프. Hoffmann-La Roche AG, 존슨 & 존슨 (제이&제이), Merck KGaA, Novartis AG, Pfizer Inc., Takeda Pharmaceutical Co. (주).

이 보고서는 이 업계에서 활동하는 회사 및 조직에 매우 귀중한 리소스입니다.. It provides a cohesive picture of the oncology drugs market to help drive informed decision making for industry executives, 정책 입안자, 학생, 및 분석가.

보고 범위

Drug class: chemotherapy, hormone therapy, immunotherapy, and targeted therapy
Indication: breast cancer, colorectal cancer, lung cancer, multiple myeloma, non-hodgkin’s lymphoma, prostate cancer, 다른 사람
지역: 북아메리카, 아시아 태평양, 유럽, 및 기타 국가 (열)
고려한 연도: 이 보고서는 기간을 다룹니다 2017 에게 2027

이해관계자를 위한 주요 이점

Get a comprehensive picture of the global oncology drugs market
성장 분야 및 투자 동향 파악
Understand what the future of the global oncology drugs market looks like
경쟁 구도 및 기회의 창 식별

목차

1. 시장 정의
2. 연구 방법론
3. 시장 데이터 & 시야
3.1 시장 가치
3.2 시장 가치 예측
4. Oncology Drugs Market by Drug Class
4.1 Chemotherapy
4.2 Hormone Therapy
4.3 Immunotherapy
4.4 Targeted Therapy
5. Oncology Drugs Market by Indication
5.1 Breast Cancer
5.2 Colorectal Cancer
5.3 Lung Cancer
5.4 Multiple Myeloma
5.5 Non-Hodgkin’s Lymphoma
5.6 Prostate Cancer
5.7 기타
6. Oncology Drugs Market by Region
6.1 북아메리카
6.2 아시아 태평양
6.3 유럽
6.4 나머지 세계 (열)
7. 회사 프로필
7.1 AbbVie Inc.
7.2 Amgen Inc.
7.3 Astellas Pharma Inc.
7.4 AstraZeneca PLC
7.5 Bristol Myers Squibb (BMS)
7.6 Eli Lilly and Company
7.7 에프. Hoffmann-La Roche AG
7.8 존슨 & 존슨 (제이&제이)
7.9 Merck KGaA
7.10 Novartis AG
7.11 Pfizer Inc.
7.12 Takeda Pharmaceutical Co., (주).
8. 부록
8.1 스트래티지헬릭스 소개
8.2 부인 성명